Drug establishmentActive, Registered FY2026FDA warning letter on file
NWL Netherlands Services B.V.
NWL Netherlands Services B.V. is an FDA-registered drug establishment (FEI 3003696942) located in . The facility is active, registered for FY2026. Its most recent FDA inspection on record (2024-10-18) was classified OAI. FDA has issued 1 warning letter(s) to this facility.
FDA warning letter
A warning letter is FDA's formal notice of significant violations that require prompt correction. It can hold up product approvals, trigger import alerts, and put supply agreements at risk until the issues are resolved and FDA closes it out.
Establishment record
Inspection history
Mar 7, 2014 · Official Action Indicated (OAI)
FDA record timeline
Combined chronology of the public records shown on this page. FDA coverage varies by dataset and year.
Questions
Is NWL Netherlands Services B.V. registered with the FDA?
Yes. NWL Netherlands Services B.V. is an FDA-registered drug establishment (FEI 3003696942) in . Its current registration status is Active, Registered FY2026.
Has NWL Netherlands Services B.V. received an FDA warning letter?
Yes. FDA issued a warning letter to NWL Netherlands Services B.V.; the most recent is dated Apr 1, 2025 (CGMP/Finished Pharmaceuticals/Adulterated).
What does NWL Netherlands Services B.V. do?
NWL Netherlands Services B.V.'s FDA-registered operations are: Analytical testing, Manufacturing, Relabeling, Repackaging.
Related facilities
Source: FDA public data · status as of 2026-08-22